Politiparty
Politiparty
LeaderboardCongressBills

118th Congress Health

H.R. 1526: Reducing Hereditary Cancer Act

Introduced

  1. Introduced (completed)Mar 9, 2023
  2. Passed House (not reached)
  3. Passed Senate (not reached)
  4. To the President (not reached)
  5. Became law (not reached)

Summary

Introduced in House, Mar 9, 2023

This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.

Written by the Congressional Research Service, Library of Congress.

Roll calls

0 votes on this bill

No roll call votes have been held on this bill.

Amendments

0 offered

No amendments were offered to this bill.

Cosponsors

71

Bipartisan support.

Who scored on this bill

18 points earned
  1. 1Debbie Wasserman Schultz D-FL SponsorDrew cross-party cosponsors, introduced, reached a cosponsor milestone4 events+18
See all scorers and every scoring event

Introductions and cosponsorships count toward weekly caps and show no points.

Other bills by Debbie Wasserman Schultz

History

  1. Mar 9, 2023Introduced in the House by Debbie Wasserman Schultz.
Show the full action history (4 actions)
  1. Dec 17, 2024Referred to the Subcommittee on Health.
  2. Mar 17, 2023Referred to the Subcommittee on Health.
  3. Mar 9, 2023Introduced in House
  4. Mar 9, 2023Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.